OMERS Administration Corp’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

OMERS Administration Corp’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-224,000	Closed	-$2.15M	–	1164
2024 Q4	$2.15M	Buy	+224,000	New	+$1.17M	0.02%	318

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

OMERS Administration Corp's PSTX Position: Q1 2025 in Review

OMERS Administration Corp sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 224,000 shares — an estimated $2.15M sold.

OMERS Administration Corp first reported a position in PSTX in Q4 2024 and held it in 1 quarter. The position peaked at $2.15M in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

OMERS Administration Corp reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
OMERS Administration Corp sold 224,000 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $2.15M.
OMERS Administration Corp first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
OMERS Administration Corp's Poseida Therapeutics, Inc. Common Stock position peaked at $2.15M in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on OMERS Administration Corp's 13F filing for Q1 2025, filed 14 May 2025.